InfuSystem Holdings Inc  

(Public, NYSEMKT:INFU)   Watch this stock  
Find more results for NYSEAMEX:INFU
+0.05 (2.70%)
Dec 9 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 1.84 - 1.95
52 week 1.55 - 3.75
Open 1.85
Vol / Avg. 39,738.00/108,988.00
Mkt cap 41.87M
P/E 9.51
Div/yield     -
EPS 0.20
Shares 22.63M
Beta 0.26
Inst. own 72%
Nov 11, 2016
Q3 2016 InfuSystem Holdings Inc Earnings Release (Estimated)
Nov 7, 2016
Q4 2016 InfuSystem Holdings Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin 3.80% 5.19%
Operating margin 7.24% 10.07%
EBITD margin - 26.19%
Return on average assets 2.90% 4.24%
Return on average equity 5.53% 7.66%
Employees 242 -
CDP Score - -


31700 Research Park Dr
United States - Map
+1-248-2911210 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


InfuSystem Holdings, Inc. is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada. Its service is to supply electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics and hospital outpatient chemotherapy clinics for the treatment of a range of cancers, including colorectal cancer, pain management and other disease states. It sells or rents new and pre-owned pole mounted and ambulatory infusion pumps to, and provides biomedical recertification, maintenance and repair services for oncology practices, as well as other alternate site settings, including home care and home infusion providers, skilled nursing facilities, pain centers and others.

Officers and directors

Eric Steen President, Chief Executive Officer, Director
Age: 58
Bio & Compensation  - Reuters
Christopher Downs Interim Chief Financial Officer, Executive Vice President
Age: 58
Bio & Compensation  - Reuters
Janet Skonieczny Chief Operating Officer, Executive Vice President, Compliance Officer and Privacy Officer
Age: 56
Bio & Compensation  - Reuters
Trent Smith Executive Vice President, Chief Accounting Officer, Corporate Controller
Age: 47
Bio & Compensation  - Reuters
Michael Milton McReynolds Executive Vice President, Chief Information Officer
Age: 46
Bio & Compensation  - Reuters
Ryan J. Morris Non-Executive Chairman of the Board
Age: 32
Bio & Compensation  - Reuters
Scott A. Shuda Director
Age: 50
Bio & Compensation  - Reuters
David C. Dreyer CPA Independent Director
Age: 59
Bio & Compensation  - Reuters
Gregg O. Lehman Ph.D. Independent Director
Age: 67
Bio & Compensation  - Reuters
Joseph E. Whitters Independent Director
Age: 57
Bio & Compensation  - Reuters